Source: Eur Respir J 2016; 47: 680-682



Rating:

Share or cite this content

Citations should be made in the following way:
van der Burgt Evelien P.M., Sturkenboom Marieke G.G., Bolhuis Mathieu S., Akkerman Onno W., Kosterink Jos G.W., de Lange Wiel C.M., Cobelens Frank G.J., van der Werf Tjip S., Alffenaar Jan-Willem C.. End TB with precision treatment!. Eur Respir J 2016; 47: 680-682

Member's Comments

No comment yet.

Related content which might interest you: The End TB Strategy Source: International Congress 2018 – The digital ®evolution in respiratory medicine: a personalised approach? Year: 2018 End of life in COPD: There may be no surprises! Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011 Digital health for the End TB Strategy: developing priority products and making them work Source: Eur Respir J 2016; 48: 29-45 Year: 2016 Intensive case-finding of TB – still needed! Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006 End of life in COPD patients: ?time for a change Source: Breathe, 13 (4) e84; 10.1183/20734735.013617 Year: 2017 Particularities of pulmonary tuberculosis in elderly Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013 Improved treatment outcome of MDR-TB in Eastern Taiwan: Reducing default rate by DOTS Plus Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 Evaluation of a tuberculosis control programme based on case-finding Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Rifampicin-resistant TB on Gene Xpert: What is the best empiric combination treatment while awaiting cultures? Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Latent TB infection: Patient choices and completion of treatment Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Adherence to the recommendation of prescribing 4 drugs in the intensive phase of the standard treatment of tuberculosis in Spain Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Is there a need for prolonged follow up in mono-drug resistant TB? Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Belief about cure of disease after dots Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Is the general population well informed about tuberculosis? Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Impact of drug injection using on TB-AIDS treatment outcomes Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Screening coverage and treatment loss to follow-up of Diabetes and Tuberculosis (TB) patients in hospitals with measures to integrate care of Diabetes and TB and those without integration measures in Malawi Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 MDR TB treatment results of GFATM program implementation in Tomsk, Russia Source: International Congress 2015 – Management of TB: a patient focus Year: 2015